Boca Raton, FL -- (SBWIRE) -- 08/06/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – Dendreon Corporation (NASDAQ:DNDN), Vringo, Inc. (NASDAQ:VRNG), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Nuverra Environmental Solutions Inc (NYSE:NES)
Dendreon Corporation (NASDAQ:DNDN) gained volume of 10.99 million shares and the average volume of the stock remained 3.13 million shares. The 52 week range of the stock remained $3.69 - $7.22 and the day range was $4.61 - $5.38.The stock opened the session at $4.61, remained amid the day range of $4.61 - $5.38, and closed the session at $5.23. The stock showed a positive performance of 13.70% in previous trading session. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients.
For How Long DNDN will Fight for Profitability? Read This Trend Analysis report
In previous session, Vringo, Inc. (NASDAQ:VRNG) traded 10.10 million shares and the average volume of the stock remained 1.99 million shares. The 52 week range of the stock remained $1.75 - $5.73. The stock was a bull and advanced 2.26%, while its closing price stayed at $3.62. The market capitalization of the stock remained 299.58 million. The half-yearly trend of the stock remained positive 14.56%.Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones.
For How Long VRNG Gloss will Attract Investors? Find out via this report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) volume of the stock was 8.29 million shares in the most recent session and the average volume remained 5.29 million shares. The stock boosted 7.93% and finished the prior session at the closing price of $7.49. The stock traded 8.29 million shares in its previous trading session and its average volume remained 5.29M shares. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors.
Will ARNA Continue To Move Higher? Find Out Here
Nuverra Environmental Solutions Inc (NYSE:NES) traded with volume of 7.32 million shares and the average volume of the stock remained 2.13 million shares. The stock decreased -1.02% and finished the trading at $2.91. The market capitalization of the stock remained 732.92 million. The beta of the stock remained 0.91. Nuverra Environmental Solutions, Inc., formerly Heckmann Corporation, provides environmental solutions to protect, enhance and advance environmental sustainability.
Will NES Get Buyers Even After The Recent Rally? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html